The role of oral disease-modifying agents glucosamine and chondroitin sulphate in the management of equine degenerative joint disease

Equine Veterinary Education

Volumn 13, Issue 4, 2001, Pages 206-215

  Platt, D ^a  

^a Woodlands   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0035599998     PISSN: 09577734     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-3292.2001.tb00092.x     Document Type: Article

References (42)

1. Basleer, C., Henrotin, Y. and Franchiment, P. (1992) In vitro evaluation of drugs proposed as chondroprotective agents. Int. J. tissue React. 14, 231-241.
2. Basleer, C., Rovati, L. and Franchiment, P. (1998b) Stimulation of proteoglycan production by glucosamine sulphate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro. Osteoarthritis Cartilage 6, 427-434.
3. Basleer, C., Combal, J.-Ph.A., Bougaret, S. and Malaise, M. (1998a) Effects of chondroitin sulphate and interleukin-1 [beta] on human articular chondrocytes cultivated in clusters. Osteoarthritis Cartilage 6, 196-204.
4. Brooks, P.M. and Ghosh, P. (1991) Chondroprotection: myth or reality. Clin. Rheum. 4, 293-303.
5. Bucci, L.R. (1994) Chondroprotective agents: Glucosamine salts and chondroitin sulphates. Townsend Let. Doctors 53-57.
6. Bucsi, L. and Poor, G. (1998) Efficacy and tolerability of oral chondroitin sulphate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis. Osteoarthritis Cartilage 6, Suppl. A, 31-36.
7. Burkhardt, D. and Ghosh, P. (1987) Laboratory evaluation of antiarthritic drugs as potential chondroprotective agents. Semin. Arth. Rheum. 17, Suppl. 1, 3-34.
8. Canapp, S.O., McLaughlin, R.M., Hoskinson, J.J., Roush, J.K. and Butine, M.D. (1999) Scintigraphic evaluation of dogs with acute synovitis after treatment with glucosamine hydrochloride and chondroitin sulphate. Am. J. vet. Res. 60, 1552-1557.
9. Conte, A., Volpi, N., Palmiera, L. and Rouca, G. (1995) Biochemical and pharmacokinetics of oral treatment with chondroitin sulphate. Drug Res. 45, 918-925.
10. Crolle, G. and D'Este, E.E. (1980) Glucosamine sulphate for the management of arthrosis: a controlled clinical investigation. Curr. med. Res. Opinion 7, 104-109.
11. Das, A., Eital, J. and Hammad, T. (1998) Efficacy of a new class of agents (glucosamine hydrochloride and chondroitin sulphate) in the treatment of osteoarthritis of the knee. Proceedings of the American Association of Hip and Knee Surgeons. 18.
12. Dorna, V.J. and Guerrero, R.C. (1998) Effects of oral and intramuscular use of chondroitin sulphate in induced equine aseptic arthritis. J. equine vet. Sci. 18, 548-555.
13. Drovanti, A., Bignamini, A. and Rovati, A. (1980) Therapeutic activity of oral glucosamine sulphate in osteoarthritis: aplacebo controlled double blind investigation. Clin. Therap. 3, 260-272.
14. Esford, L.E., Maiti, A., Bader, S.A., Tufaro, F. and Johnson, P. (1998) Analysis of CD44 interaction with hyaluronan in murine L cell fibroblasts deficient in glycosaminoglycan synthesis: a role for chondroitin sulphate. J. cell Sci. 111, 1021-1029.
15. Ghosh, P., Smith, M. and Wells, C. (1992) Second-line agents in osteoarthritis. In: Second-Line Agents in Treatment of Rheumatic Disease, Eds: J.S. Dixon and D.E. Furst, Marcell Dekker, New York. pp 363-427.
16. Glade, M.J. (1990) Polysulphated glycosaminoglycans accelerates the net synthesis of collagen and glycosaminoglycans by arthritic equine cartilage and chondrocytes. Am. J. vet. Res. 51, 779-785.
17. Hanson, R.R., Smalley, L.R., Huff, G.K., White, S. and Hammad, T.A. (1997a) Oral treatment with a glucosamine-chondroitin sulphate compound for degenerative joint disease in horses: 25 cases. Equine Pract. 19, 16-22.
18. Hanson, RR., Hammad, T.A. and Brawner, W.R. (1997b) Evaluation of the clinical efficiency of cosequin in the treatment of navicular disease: a double-blind placebo-controlled randomised clinical trial. J. equine vet. Sci. 17, 484.
19. Hanson, R.R., Smalley, L.R., Huff, G.K., White, S. and Hammad T.A. (1997c) Oral treatment with a glucosamine-chondroitin sulphate compound for degenerative joint disease in horses: 25 cases. Vet. comp. Orthop. Traumatol. 10, 76.
20. Jimenez, S.A. and Dodge, G.R. (1997) The effects of glucosamine sulphate on human chondrocyte gene expression. Osteoarthritis 5, Suppl. A, 72.
21. Leffler, C.T., Philippi, A.F., Leffler, S.G., Mosure, J.C. and Kim, P.D. (1999) Glucosamine, chondroitin sulphate and manganese ascorbate for degenerative joint disease of the knee or low back: a randomised, double-blind, placebo-controlled pilot study. Mil. Med. 164, 85-91.
22. Lippiello, L., Woodward, J., Karpman, R. and Hammad, T.A. (1999) Beneficial Effect of Cartilage Disease-Modifying Agents Tested in Chondrocytes and a Rabbit Instability Model of Osteoarthritis. MA Thesis, University of Boston.
23. Lopez, V.A. (1982) Double-blind clinical evaluation of the relative efficiency of ibuprofen and glucosamine sulphate in the management of osteoarthritis of the knee in out-patients. Curr. med. Res. Opinion 8, 145-149.
24. McCarty, M.F. (1998) Enhanced synovial production of hyaluronic acid may explain rapid clinical response to high-dose glucosamine in osteoarthritis. Med. Hypotheses 50, 507-510.
25. McNamara, P.S., Barr, S.C., Idouraine, A. and Lipiello, L. (1997) Effects of an oral chondroprotective agent on cartilage metabolism and canine serum. Proceedings of the 24th Annual Veterinary Orthopaedic Society Meeting. p 34.
26. Morreale, P., Manopulo, R., Galati, M., Boccanera, L. and Bocchi, L. (1996) Comparison of the anti-inflammatory efficacy of chondroitin sulphate and diclofenac sodium in patients with knee osteoarthritis. J. Rheumatol. 23, 1385-1391.
27. Morrison, L.M. and Scheide, O.A. (1974) Prevention and treatment of ischaemic heart disease in human patients. In: Coronary Heart Disease and the Mucopolysaccharides (Glycosaminoglycans), Ed: L.M. Morrison and C.C. Thomas, Springfield, Massachusetts. pp 185-204.
28. Qiu, G.X., Gao, S.N., Giacovelli, G., Rovati, L. and Sitnikar, I. (1998) Efficacy and safety of glucosamine sulphate versus ibuprofen in patients with knee arthritis. Drug Res. 48, 469-474.
29. Palmieri, L., Conte, A., Giovannini, L., Lualdi, P. and Ronca, G. (1990) Metabolic fate of exogenous chondroitin sulphate in the experimental animal. Drug Res. 40, 318-323.
30. Ronca, F., Palmieri, P. and Ronca, G. (1998) Anti-inflammatory activity of chondroitin sulphate. Osteoarthritis 6, Suppl. A, 14-21.
31. Russell, A.L. (1998) Glucosamine in osteoarthritis and gastrointestinal disorders: an example of the need for a paradigm shift. Med. Hypotheses 51, 347-349.
32. 14-glucosamine to the rat. Pharmacotherap. 3, 538-550.
33. Setnikar, I., Gaiccheti, C. and Zanolo, G. (1986) Pharmacokinetics of glucosamine in the dog and man. Drug Res. 36, 729-735.
34. Sitnikar, I., Pacini, M.A. and Revel, L. (1991) Antiarthritic effects of glucosamine sulphate studied in animal models. Drug Res. 41, 542-545.
35. Setnikar, I., Palumbo, R., Canali, S. and Zanolo, G. (1993) Pharmacokinetics of glucosamine in man. Drug Res. 43, 1109-1113.
36. Shankland, W.E. (1998) The effects of glucosamine and chondroitin sulphate on osteoarthritis of the TMJ: a preliminary report of 50 patients. Cranio. 16, 230-235.
37. Talent, J.M. and Gracy, R.W. (1996) Pilot study of oral polymeric N-acetyl-D-glucosamine as a potential treatment for patients with osteoarthritis. Clin. Therap. 18, 1184-1190.
38. Tesorlere, G., Dones, F. and Magistro, D. (1992) Intestinal absorption of glucosamine and N-acetylglucosamine. Experertia 28, 770-776.
39. Uebelhart, D., Zhang, J., Thonar, E.J.M.A. and Williams, J.M. (1997) Acute degeneration of articular cartilage in the rabbit: Protective effect of chondroitin 4 and 6 sulphate. Osteoarthritis 5, Suppl. A, 68.
40. Uebelhart, D., Thonar, E.J., Delmas, P.D., Chantraine, A. and Vignon, E. (1998) Effects of oral chondroitin sulphate on the progression of knee osteoarthritis: a pilot study. Osteoarthritis Cartilage 6, 39-46.
41. Verbruggen, G., Goemaere, S. and Veys, E.M. (1998) Chondroitin sulphate (structure/disease modifying anti-osteoarthritis drug) in the treatment of finger joint osteoarthritis. Osteoarthritis Cartilage 6, 37-38.
42. Vidal, Y., Plana, R. and Bizzari, D. (1978) Articular cartilage pharmacology: in vitro studies on glucosamine and nonsteroidal anti-inflammatory drugs. Pharmacol. Res. Comm. 10, 557-569.